Times Square Capital Management, LLC Sage Therapeutics, Inc. Transaction History

Times Square Capital Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 08, 2020	SELL	$26.15 - $77.24 $14.4 Million - $42.5 Million	-550,075 Closed	0 $0
Q4 2019 Feb 05, 2020	SELL	$60.18 - $154.77 $1.23 Million - $3.16 Million	-20,425 Reduced 3.58%	550,075 $39.7 Million
Q3 2019 Nov 05, 2019	BUY	$140.29 - $189.96 $8.63 Million - $11.7 Million	61,500 Added 12.08%	570,500 $80 Million
Q2 2019 Aug 02, 2019	BUY	$157.85 - $183.09 $2.18 Million - $2.53 Million	13,800 Added 2.79%	509,000 $93.2 Million
Q1 2019 May 10, 2019	BUY	$89.33 - $163.65 $44.2 Million - $81 Million	495,200 New	495,200 $78.8 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $333M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Times Square Capital Management, LLC with notifications on news.